Road to RSNA 2020: Women's Imaging
By Theresa Pablos, AuntMinnie.com staff writerNovember 16, 2020
November 16, 2020
Breast imagers are particularly looking forward to new breast MRI research at RSNA and beyond. In our preview, experts pointed to MRI's sensitivity as the force behind its continued staying power in women's imaging and discussed improvements, such as abbreviated protocols, that make MRI more feasible as a screening modality.
They also pointed to contrast-enhanced digital mammography (CEDM) as a topic to look for at RSNA 2020 and future conferences. Early research shows the sensitivity of CEDM rivals that of MRI, but CEDM can be performed in open spaces and at a much lower cost. One day, CEDM may even be used alongside MRI and digital breast tomosynthesis to help further personalize screening based on a patient's risk factors.
However, one of the most popular women's imaging topics at RSNA will be the use of artificial intelligence (AI) to improve screening mammography outcomes. While AI applications still have a way to go, experts in our preview discussed some of the AI advancements that could improve clinical outcomes.
Our preview also covers larger trends that have affected women's imaging in 2020, including the novel coronavirus pandemic and new research on the benefits of screening mammography.
COVID-19 casts long shadow on women's imaging
As with the rest of radiology, women's imaging in 2020 has been marked by the COVID-19 pandemic, which has resulted in drastic drops in imaging volume. At the same time, nagging questions persist about whether mammography screening exams postponed due to COVID-19 could result in higher breast cancer rates later on. Discuss
As with the rest of radiology, women's imaging in 2020 has been marked by the COVID-19 pandemic, which has resulted in drastic drops in imaging volume. At the same time, nagging questions persist about whether mammography screening exams postponed due to COVID-19 could result in higher breast cancer rates later on. Discuss
Understanding Tyrer-Cuzick breast cancer risk assessment in clinical practice
Breast cancer screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment. Currently, the most comprehensive breast cancer risk assessment model available is the Tyrer-Cuzick risk model version 8 (TCv8). However, there is little information about how to use TCv8 clinically to obtain the most accurate lifetime risk estimates. Discuss
Breast cancer screening is rapidly moving into an era of personalized care, where prevention, early detection, and treatment are guided by risk assessment. Currently, the most comprehensive breast cancer risk assessment model available is the Tyrer-Cuzick risk model version 8 (TCv8). However, there is little information about how to use TCv8 clinically to obtain the most accurate lifetime risk estimates. Discuss
3 topics shaping the future of women's imaging
Breast imagers will have a wide variety of scientific content in women's imaging to see at the RSNA 2020 virtual meeting. From efforts to personalize breast screening to cutting-edge techniques changing the way breast cancer is treated, researchers are working to improve the entire continuum of breast care. Discuss
Breast imagers will have a wide variety of scientific content in women's imaging to see at the RSNA 2020 virtual meeting. From efforts to personalize breast screening to cutting-edge techniques changing the way breast cancer is treated, researchers are working to improve the entire continuum of breast care. Discuss